Nasdaq · CIK 0001448431
OPRX OptimizeRx Corp
Insider trading from SEC Form 4. Last filing 11 d ago. Close $8.28 on Oct 9, 2026, +82% from the 52-week low and -62% from the high.
OptimizeRx Corp (OPRX) has 57 SEC Form 4 filings on file from 9 insiders, the latest filed on Oct 2, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
4 open-market trades have been scored at OPRX. The newest: Edward Stelmakh (Chief Finance & Strat Officer) sold $19k of stock on Dec 19, 2025, filed Dec 22, 2025, scored 7 (weak). The largest of the 4 shown: Patrick D Spangler (director) sold $194k on Aug 28, 2025, scored 32 (weak).
OPRX closed at $8.28 on Oct 9, 2026, 82% above its 52-week low and 62% below its 52-week high.
1 Form 144 notice of planned sales is on file, the latest filed Aug 29, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at OptimizeRx Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | Edward Stelmakh Chief Finance & Strat Officer sell | $19k 1,388 shares | -1% | +226% from low-38% from high | |
| 15Weak | Stephen L Silvestro Chief Executive Officer sell | $30k 1,620 shares | -1% | +390% from low-9% from high | |
| 32Weak | Patrick D Spangler director sell | $194k 11,120 shares | -20% | +376% from low0% from high | |
| 35Weak | William J Febbo CEO buy | $100k 20,000 shares | +3% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 29, 2025 | Spangler Patrick D Director | 11,120 0.06% of outstanding | $198k | Aug 28, 2025 | none |
Transactions
The newest 50 of 108 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Andrew J. D'Silva Chief Business Officer | FTax withholding Common Stock | -414 | $8.39 | $3,473 | 99,246 | 11 d ago |
| Sep 1, 2026 | Andrew J. D'Silva Chief Business Officer | FTax withholding Common Stock | -1,432 | $7.86 | $11k | 99,660 | 41 d ago |
| May 15, 2026 | Theresa Greco Chief Commercial Officer | FTax withholding Common Stock | -914 | $5.21 | $4,762 | 71,954 | May 18, 2026 |
| May 15, 2026 | Theresa Greco Chief Commercial Officer | FTax withholding Common Stock | -879 | $5.21 | $4,580 | 71,075 | May 18, 2026 |
| Feb 11, 2026 | Marion Odence-Ford Chief Legal & Admin Officer | MOption exercise Common Stock | +4,000 | - | - | 93,322 | Feb 13, 2026 |
| Feb 11, 2026 | Marion Odence-Ford Chief Legal & Admin Officer | FTax withholding Common Stock | -1,386 | $9.23 | $13k | 91,936 | Feb 13, 2026 |
| Feb 11, 2026 | Marion Odence-Ford Chief Legal & Admin Officer | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 0 | Feb 13, 2026 |
| Dec 23, 2025 | Edward Stelmakh Chief Finance & Strat Officer | FTax withholding Common Stock | -3,658 | $12.74 | $47k | 123,172 | Dec 23, 2025 |
| Dec 23, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | FTax withholding Common Stock | -4,051 | $12.74 | $52k | 89,322 | Dec 23, 2025 |
| Dec 19, 2025 | Edward Stelmakh Chief Finance & Strat Officer | MOption exercise Common Stock | +5,237 | $0.00 | $0 | 128,218 | Dec 23, 2025 |
| Dec 23, 2025 | Stephen L Silvestro Chief Executive Officer | FTax withholding Common Stock10b5-1 | -3,361 | $12.74 | $43k | 190,507 | Dec 23, 2025 |
| Dec 23, 2025 | Stephen L Silvestro Chief Executive Officer | FTax withholding Common Stock | -3,361 | $12.74 | $43k | 190,507 | Dec 23, 2025 |
| Dec 23, 2025 | Doug Besch Chief Product & Tech Officer | FTax withholding Common Stock | -4,079 | $12.74 | $52k | 66,876 | Dec 23, 2025 |
| Dec 23, 2025 | Theresa Greco Chief Commercial Officer | FTax withholding Common Stock | -1,420 | $12.74 | $18k | 72,868 | Dec 23, 2025 |
| Dec 19, 2025 | Edward Stelmakh Chief Finance & Strat Officer | FTax withholding Common Stock | -1,388 | $13.51 | $19k | 126,830 | Dec 23, 2025 |
| Dec 19, 2025 | Edward Stelmakh Chief Finance & Strat Officer | MOption exercise Restricted Stock Unitsderivative | -5,237 | $0.00 | $0 | 5,237 | Dec 23, 2025 |
| Dec 19, 2025 | Andrew J. D'Silva Chief Business Officer | FTax withholding Common Stock | -703 | $13.51 | $9,498 | 44,735 | Dec 22, 2025 |
| Dec 19, 2025 | Brendan W. Merrell CHIEF OPERATING OFFICER | FTax withholding Common Stock | -289 | $13.51 | $3,904 | 26,207 | Dec 22, 2025 |
| Dec 19, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | MOption exercise Common Stock | +3,928 | $0.00 | $0 | 94,526 | Dec 22, 2025 |
| Dec 19, 2025 | Edward Stelmakh Chief Finance & Strat Officer | MOption exercise Common Stock | +5,237 | $0.00 | $0 | 128,218 | Dec 22, 2025 |
| Dec 19, 2025 | Stephen L Silvestro Chief Executive Officer | MOption exercise Common Stock | +6,546 | $0.00 | $0 | 195,462 | Dec 22, 2025 |
| Dec 19, 2025 | Doug Besch Chief Product & Tech Officer | MOption exercise Common Stock | +1,964 | $0.00 | $0 | 71,536 | Dec 22, 2025 |
| Dec 19, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | FTax withholding Common Stock | -1,153 | $13.51 | $16k | 93,373 | Dec 22, 2025 |
| Dec 19, 2025 | Stephen L Silvestro Chief Executive Officer | FTax withholding Common Stock | -1,594 | $13.51 | $22k | 193,868 | Dec 22, 2025 |
| Dec 19, 2025 | Edward Stelmakh Chief Finance & Strat Officer | SOpen-market sale Common Stock | -1,388 | $13.51 | $19k | 126,830 | Dec 22, 2025 |
| Dec 19, 2025 | Doug Besch Chief Product & Tech Officer | FTax withholding Common Stock | -581 | $13.51 | $7,849 | 70,955 | Dec 22, 2025 |
| Dec 19, 2025 | Doug Besch Chief Product & Tech Officer | MOption exercise Restricted Stock Unitsderivative | -1,964 | $0.00 | $0 | 1,964 | Dec 22, 2025 |
| Dec 19, 2025 | Edward Stelmakh Chief Finance & Strat Officer | MOption exercise Restricted Stock Unitsderivative | -5,237 | $0.00 | $0 | 5,237 | Dec 22, 2025 |
| Dec 19, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | MOption exercise Restricted Stock Unitsderivative | -3,928 | $0.00 | $0 | 3,928 | Dec 22, 2025 |
| Dec 19, 2025 | Stephen L Silvestro Chief Executive Officer | MOption exercise Restricted Stock Unitsderivative | -6,546 | $0.00 | $0 | 6,547 | Dec 22, 2025 |
| Dec 11, 2025 | Brendan W. Merrell CHIEF OPERATING OFFICER | FTax withholding Common Stock | -712 | $14.03 | $9,989 | 26,496 | Dec 15, 2025 |
| Dec 11, 2025 | Andrew J. D'Silva Chief Business Officer | FTax withholding Common Stock | -868 | $14.03 | $12k | 45,438 | Dec 15, 2025 |
| Aug 21, 2025 | Brendan W. Merrell CHIEF OPERATING OFFICER | AGrant or award Common Stock | +10,417 | $0.00 | $0 | 27,691 | Nov 10, 2025 |
| Oct 3, 2025 | Brendan W. Merrell CHIEF OPERATING OFFICER | FTax withholding Common Stock | -483 | $18.75 | $9,056 | 27,208 | Nov 10, 2025 |
| Aug 21, 2025 | Brendan W. Merrell CHIEF OPERATING OFFICER | AGrant or award Stock Optionderivative | +23,437 | $0.00 | $0 | 46,874 | Nov 10, 2025 |
| Oct 1, 2025 | Andrew J. D'Silva Chief Business Officer | FTax withholding Common Stock | -414 | $18.98 | $7,858 | 47,100 | Nov 7, 2025 |
| Oct 3, 2025 | Andrew J. D'Silva Chief Business Officer | FTax withholding Common Stock | -794 | $18.75 | $15k | 46,306 | Nov 7, 2025 |
| Nov 1, 2025 | Theresa Greco Chief Commercial Officer | FTax withholding Common Stock | -1,693 | $20.49 | $35k | 74,288 | Nov 3, 2025 |
| Oct 3, 2025 | Doug Besch Chief Product & Tech Officer | MOption exercise Common Stock | +3,325 | $0.00 | $0 | 70,555 | Oct 7, 2025 |
| Oct 3, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | MOption exercise Common Stock | +6,649 | $0.00 | $0 | 92,550 | Oct 7, 2025 |
| Oct 3, 2025 | Edward Stelmakh Chief Finance & Strat Officer | MOption exercise Common Stock | +16,623 | $0.00 | $0 | 127,387 | Oct 7, 2025 |
| Oct 3, 2025 | Stephen L Silvestro Chief Executive Officer | MOption exercise Common Stock | +6,649 | $0.00 | $0 | 190,536 | Oct 7, 2025 |
| Aug 21, 2025 | Andrew J. D'Silva Chief Business Officer | AGrant or award Common Stock | +10,417 | $0.00 | $0 | 47,514 | Oct 7, 2025 |
| Oct 3, 2025 | Doug Besch Chief Product & Tech Officer | FTax withholding Common Stock | -983 | $18.75 | $18k | 69,572 | Oct 7, 2025 |
| Oct 3, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | FTax withholding Common Stock | -1,952 | $18.75 | $37k | 90,598 | Oct 7, 2025 |
| Oct 3, 2025 | Edward Stelmakh Chief Finance & Strat Officer | FTax withholding Common Stock | -4,406 | $18.75 | $83k | 122,981 | Oct 7, 2025 |
| Oct 3, 2025 | Stephen L Silvestro Chief Executive Officer | SOpen-market sale Common Stock | -1,620 | $18.75 | $30k | 188,916 | Oct 7, 2025 |
| Aug 21, 2025 | Andrew J. D'Silva Chief Business Officer | AGrant or award Stock Optionderivative | +23,437 | $0.00 | $0 | 23,437 | Oct 7, 2025 |
| Oct 3, 2025 | Doug Besch Chief Product & Tech Officer | MOption exercise Restricted Stock Unitsderivative | -3,325 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Oct 3, 2025 | Marion Odence-Ford Chief Legal & Admin Officer | MOption exercise Restricted Stock Unitsderivative | -6,649 | $0.00 | $0 | 0 | Oct 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Doug BeschChief Product & Tech Officer
- Andrew J. D'SilvaChief Business Officer
- William J FebboCEO
- Theresa GrecoChief Commercial Officer
- Brendan W. MerrellCHIEF OPERATING OFFICER
- Marion Odence-FordChief Legal & Admin Officer
- Stephen L SilvestroChief Executive Officer
- Patrick D Spanglerdirector
- Edward StelmakhChief Finance & Strat Officer
Questions about OPRX
Answered from the filings on this page, as of the latest one.
Are insiders buying OPRX?
No. In the last 90 days no insider at OptimizeRx Corp bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade OPRX on the open market?
Edward Stelmakh (Chief Finance & Strat Officer) sold $19k of OPRX on Dec 19, 2025 and filed the Form 4 on Dec 22, 2025. InsiderTell scored 7 (weak).
How many insiders file Form 4 at OptimizeRx Corp?
9 people have filed a Form 4 at OptimizeRx Corp, among them Doug Besch (Chief Product & Tech Officer), Andrew J. D'Silva (Chief Business Officer), William J Febbo (CEO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.